Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mariona Cabo

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Oncoimmunology|December 7, 2017
Trial Watch: Immunostimulatory monoclonal antibodies for oncological indicationsMariona Cabo, Rienk Offringa, Laurence Zitvogel, et al.
Frontiers in Immunology|November 29, 2017
Interplay between Natural Killer Cells and Anti-HER2 Antibodies: Perspectives for Breast Cancer ImmunotherapyAura Muntasell, Mariona Cabo, Sonia Servitja, et al.
Current Opinion in Immunology|February 26, 2017
Targeting NK-cell checkpoints for cancer immunotherapyAura Muntasell, Maria C Ochoa, Luna Cordeiro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 8, 2018
NK Cell Infiltrates and HLA Class I Expression in Primary HER2<sup>+</sup> Breast Cancer Predict and Uncouple Pathological Response and Disease-free SurvivalAura Muntasell, Federico Rojo, Sonia Servitja, et al.
Cancer Immunology Research|September 28, 2021
CD137 Costimulation Counteracts TGFβ Inhibition of NK-cell Antitumor FunctionMariona Cabo, Sara Santana-Hernández, Marcel Costa-Garcia, et al.
Cancer Immunology Research|June 14, 2019
High Numbers of Circulating CD57<sup>+</sup> NK Cells Associate with Resistance to HER2-Specific Therapeutic Antibodies in HER2<sup>+</sup> Primary Breast CancerAura Muntasell, Sònia Servitja, Mariona Cabo, et al.
Nature Immunology|March 22, 2025
Enhancing human NK cell antitumor function by knocking out SMAD4 to counteract TGFβ and activin A suppressionAnna Rea, Sara Santana-Hernández, Javier Villanueva, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Oncoimmunology|December 7, 2017
Trial Watch: Immunostimulatory monoclonal antibodies for oncological indicationsMariona Cabo, Rienk Offringa, Laurence Zitvogel, et al.
Frontiers in Immunology|November 29, 2017
Interplay between Natural Killer Cells and Anti-HER2 Antibodies: Perspectives for Breast Cancer ImmunotherapyAura Muntasell, Mariona Cabo, Sonia Servitja, et al.
Current Opinion in Immunology|February 26, 2017
Targeting NK-cell checkpoints for cancer immunotherapyAura Muntasell, Maria C Ochoa, Luna Cordeiro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 8, 2018
NK Cell Infiltrates and HLA Class I Expression in Primary HER2<sup>+</sup> Breast Cancer Predict and Uncouple Pathological Response and Disease-free SurvivalAura Muntasell, Federico Rojo, Sonia Servitja, et al.
Cancer Immunology Research|September 28, 2021
CD137 Costimulation Counteracts TGFβ Inhibition of NK-cell Antitumor FunctionMariona Cabo, Sara Santana-Hernández, Marcel Costa-Garcia, et al.
Cancer Immunology Research|June 14, 2019
High Numbers of Circulating CD57<sup>+</sup> NK Cells Associate with Resistance to HER2-Specific Therapeutic Antibodies in HER2<sup>+</sup> Primary Breast CancerAura Muntasell, Sònia Servitja, Mariona Cabo, et al.
Nature Immunology|March 22, 2025
Enhancing human NK cell antitumor function by knocking out SMAD4 to counteract TGFβ and activin A suppressionAnna Rea, Sara Santana-Hernández, Javier Villanueva, et al.
Pageof 1